Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free SNPHY Stock Alerts

Santen Pharmaceutical (SNPHY) Stock Chart & Stock Price History

Santen Pharmaceutical logo
$11.80 -0.20 (-1.67%)
As of 02:52 PM Eastern
Compare

Santen Pharmaceutical Stock Price Performance

The Santen Pharmaceutical (SNPHY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 0.60%, with a year-to-date return of 14.56%. In the past month, the stock has increased 0.54%, reflecting recent market activity.

As of the latest close, Santen Pharmaceutical traded at $12.00 with a market cap of $3.87 billion and volume of 659 shares. Five years ago, the stock traded at $13.92, representing a 15.23% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 41,406 shares.

Receive SNPHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-3.44%
1 Month
Performance
+0.54%
3 Month
Performance
+16.37%
Year-To-Date
Performance
+14.56%
1 Year
Performance
+0.60%
5 Year
Performance
-15.23%

SNPHY Stock Chart for Monday, June, 15, 2026

SNPHY Chart by TradingView

Santen Pharmaceutical Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/15/2026$12.00$11.80
-1.67%		$11.80$11.462,785 shs$3.80 billion
06/12/2026$12.47$12.00
-3.77%		$12.00$12.00659 shs$3.87 billion
06/11/2026$12.22$12.47
+2.05%		$12.47$11.65959 shs$4.02 billion
06/10/2026$12.23$12.22
-0.11%		$12.45$12.041,063 shs$3.94 billion
06/09/2026$12.15$12.23
+0.68%		$12.32$11.731,607 shs$3.94 billion
06/08/2026$11.75$12.15
+3.38%		$12.20$12.036,408 shs$3.92 billion
06/05/2026$11.88$11.75
-1.03%		$12.51$11.751,080 shs$3.79 billion
06/04/2026$11.93$11.88
-0.46%		$11.88$11.7217,613 shs$3.83 billion
06/03/2026$11.22$11.93
+6.33%		$11.96$11.612,012 shs$3.84 billion
06/02/2026$11.79$11.22
-4.79%		$11.67$11.22883 shs$3.62 billion
06/01/2026$12.03$11.79
-2.04%		$12.09$11.701,533 shs$3.80 billion
05/29/2026$11.72$12.03
+2.67%		$12.03$12.03514 shs$3.88 billion
05/28/2026$11.98$11.72
-2.21%		$12.01$11.711,062 shs$3.78 billion
05/27/2026$12.57$11.98
-4.68%		$11.98$11.84874 shs$3.86 billion
05/26/2026$11.97$12.57
+5.01%		$12.57$11.907,036 shs$4.05 billion
05/25/2026$11.97$11.97$11.97$11.97602 shs$3.86 billion
05/22/2026$11.87$11.97
+0.86%		$11.97$11.97602 shs$3.86 billion
05/21/2026$11.88$11.87
-0.10%		$11.87$11.75969 shs$3.82 billion
05/20/2026$11.99$11.88
-0.92%		$12.42$11.85919 shs$3.83 billion
05/19/2026$11.94$11.99
+0.40%		$11.99$11.912,708 shs$3.86 billion
05/18/2026$11.74$11.94
+1.75%		$12.05$11.631,716 shs$3.85 billion
05/15/2026$11.90$11.74
-1.37%		$11.74$11.74740 shs$3.78 billion
05/14/2026$11.41$11.90
+4.29%		$11.90$11.573,291 shs$3.84 billion
Related Companies

This page (OTCMKTS:SNPHY) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel